Malignant Brain Tumors Active Not Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Malignant Brain Tumor

IndicationStatusPhase
DBCOND0050591 (Malignant Brain Tumors)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02798406Combination Adenovirus + Pembrolizumab to Trigger Immune Virus EffectsTreatment